Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND

Journal of NeuroVirology

Volumn 19, Issue 2, 2013, Pages 137-143

  Chalermchai, Thep ^a   Valcour, Victor ^b,c   Sithinamsuwan, Pasiri ^d   Pinyakorn, Suteeraporn ^e   Clifford, David ^f   Paul, Robert H ^g   Tipsuk, Somporn ^a   Fletcher, James L K ^a   Degruttola, Victor ^h   Ratto Kim, Silvia ^j   Hutchings, Nicholas ^b   Shikuma, Cecilia ^k   Ananworanich, Jintanat ^a,e,i  

^a THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^e THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ CHULALONGKORN UNIVERSITY   (Thailand)

^j WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^k UNIVERSITY OF HAWAII   (United States)

more..

Author keywords

Asia; HIV dementia; Neuropsychological tests; Neuropsychology; Trail Making Test

Indexed keywords

ADULT; APTITUDE TEST; ARTICLE; CLINICAL TRIAL; CONSENSUS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HIV ASSOCIATED DEMENTIA; HUMAN; INSTRUMENT VALIDATION; INTERNATIONAL HIV DEMENTIA SCALE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE; THAILAND; TRAIL MAKING TEST A;

ADULT; AIDS DEMENTIA COMPLEX; FEMALE; HUMANS; MALE; MILD COGNITIVE IMPAIRMENT; RESEARCH DESIGN; ROC CURVE; SEVERITY OF ILLNESS INDEX; THAILAND; TRAIL MAKING TEST;

EID: 84882572500     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-013-0151-4     Document Type: Article

References (46)

1. Albert SM, Weber CM, Todak G et al (1999) An observed performance test of medication management ability in HIV: relation to neuropsychological status and medication adherence outcomes. AIDS Behav 3:121-128
2. Antinori A, Arendt G, Becker JT et al (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789-1799
3. Ardila A (2005) Cultural values underlying psychometric cognitive testing. Neuropsychol Rev 15:185-195
4. Bottiggi KA, Chang JJ, Schmitt FA et al (2007) The HIV Dementia Scale: predictive power in mild dementia and HAART. J Neurol Sci 260:11-15
5. Breuer E, Stoloff K, Myer L, Seedat S, Stein DJ, Joska J (2011) Reliability of the lay adherence counsellor administered substance abuse and mental illness symptoms screener (SAMISS) and the International HIV Dementia Scale (IHDS) in a primary care HIV clinic in Cape Town, South Africa. AIDS Behav 16:1464-1471
6. Chan LG, Kandiah N, Chua A (2012) HIV-associated neurocognitive disorders (HAND) in a South Asian population - contextual application of the 2007 criteria. BMJ open 2:e000662
7. Choi Y, Townend J, Vincent T et al (2011) Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa. J Neurovirol 17:166-175
8. Deshpande AK, Patnaik MM (2005) Nonopportunistic neurologic manifestations of the human immunodeficiency virus: an Indian study. J Int AIDS Soc 7:2
9. Filho SM, de Melo HR (2012) Frequency and risk factors for HIV-associated neurocognitive disorder and depression in older individuals with HIV in northeastern Brazil. Int Psychogeriatr 24:1648-55
10. Gandhi NS, Moxley RT, Creighton J et al (2010) Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder. HIV Ther 4:371-379
11. Graham DP, Kunik ME, Doody R, Snow AL (2005) Self-reported awareness of performance in dementia. Brain Res Cogn Brain Res 25:144-152
12. Heaps JM, Valcour V, Chalermchai T, Paul R, Rattanamanee S, Siangphoe U, Sithinamsuwan P, Chairangsaris P, Nidhindandana S, Tipsuk S, Suttichom D, Fletcher J, Shikuma C, Anaworanich J (2013) Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders. J Clin Exp Neuropsychol (In press)
13. Heaton RK, Marcotte TD, Mindt MR et al (2004) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10:317-331
14. Heaton RK, Clifford DB, Franklin DR Jr et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087-2096
15. Heaton RK, Franklin DR, Ellis RJ et al (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3-16
16. Hinkin CH, Hardy DJ, Mason KI et al (2004) Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS 18(Suppl 1):S19-25
17. Holguin A, Banda M, Willen EJ et al (2011) HIV-1 effects on neuropsychological performance in a resource-limited country, Zambia. AIDS Behav 15:1895-1901
18. Joint United Nations Programme on HIV/AIDS (2010) Global report: UNAIDS report on the global AIDS epidemic. In Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS, 2010: v.
19. Joska JA, Westgarth-Taylor J, Hoare J et al (2011) Validity of the International HIV Dementia Scale in South Africa. AIDS Patient Care STDS 25:95-101
20. Kwasa J, Cettomai D, Lwanya E et al (2012) Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya. PLoS One 7:e32898
21. Lopardo GD, Bissio E, Iannella Mdel C, Crespo AD, Garone DB, Cassetti LI (2009) Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 infection. J Acquir Immune Defic Syndr 52:488-492
22. Maj M, Janssen R, Starace F et al (1994) WHO Neuropsychiatric AIDS study, cross-sectional phase I. Study design and psychiatric findings. Arch Gen Psychiatry 51:39-49
23. McArthur JC (2004) HIV dementia: an evolving disease. J Neuroimmunol 157:3-10
24. McArthur JC, Brew BJ, Nath A (2005) Neurological complications of HIV infection. Lancet Neurol 4:543-555
25. McArthur JC, Steiner J, Sacktor N, Nath A (2010) Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol 67:699-714
26. Mohamed MA, Barker PB, Skolasky RL et al (2010) Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study. Magn Reson Imaging 28:1251-1257
27. Morgan EE, Woods SP, Scott JC et al (2008) Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale. J Clin Exp Neuropsychol 30:83-90
28. Njamnshi AK, Djientcheu Vde P, Fonsah JY, Yepnjio FN, Njamnshi DM, The MWE, International HIV (2008) Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaounde-Cameroon. J Acquir Immune Defic Syndr 49:393-397
29. Patel VN, Mungwira RG, Tarumbiswa TF, Heikinheimo T, van Oosterhout JJ (2010) High prevalence of suspected HIV-associated dementia in adult Malawian HIV patients. Int J STD AIDS 21:356-358
30. Power C, Selnes OA, Grim JA, McArthur JC (1995) HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol 8:273-278
31. Riedel D, Ghate M, Nene M et al (2006) Screening for human immunodeficiency virus (HIV) dementia in an HIV clade C-infected population in India. J Neurovirol 12:34-38
32. Robbins RN, Remien RH, Mellins CA, Joska JA, Stein DJ (2011) Screening for HIV-associated dementia in South Africa: potentials and pitfalls of task-shifting. AIDS Patient Care STDS 25:587-593
33. Royal W 3rd, Cherner M, Carr J et al (2012) Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria. J Neurovirol 18:191-199
34. Sacktor NC, Bacellar H, Hoover DR et al (1996) Psychomotor slowing in HIV infection: a predictor of dementia. AIDS and death J Neurovirol 2:404-410
35. Sacktor N, McDermott MP, Marder K et al (2002) HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 8:136-142
36. Sacktor NC, Wong M, Nakasujja N et al (2005) The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 19:1367-1374
37. Simioni S, Cavassini M, Annoni JM et al (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24:1243-1250
38. Singh D, Sunpath H, John S, Eastham L, Gouden R (2008) The utility of a rapid screening tool for depression and HIV dementia amongst patients with low CD4 counts - a preliminary report. Afr J Psychiatry (Johannesbg) 11:282-286
39. Sungkanuparph S, Techasathit W, Utaipiboon C et al (2010) Thai national guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2010. Asian Biomed 4:515-528
40. Valcour VG (2011) Evaluating cognitive impairment in the clinical setting: practical screening and assessment tools. Top Antivir Med 19:175-180
41. Valcour VG, Sithinamsuwan P, Nidhinandana S et al (2007) Neuropsychological abnormalities in patients with dementia in CRF 01-AE HIV-1 infection. Neurology 68:525-527
42. Valcour VG, Chiao S, Rosen HJ, et al. (2011) Functional deficits identified in patients with Asymptomatic Neurocognitive Impairment (ANI) track to changes in brain integrity and size. In: 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012). Seattle, WA
43. Vivithanaporn P, Heo G, Gamble J et al (2010) Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology 75:1150-1158
44. Williamson C, Alcantar O, Rothlind J, Cahn-Weiner D, Miller BL, Rosen HJ (2010) Standardised measurement of self-awareness deficits in FTD and AD. J Neurol Neurosurg Psychiatry 81:140-145
45. Zhang Y, Qiao L, Ding W et al (2012) An initial screening for HIV-associated neurocognitive disorders of HIV-1 infected patients in China. J Neurovirol 18:120-126
46. Zhao TT, Feng QM, Liang H, Tang XY, Wei B (2011) An exploratory study on the diagnostic cutoff value of International HIV-associated Dementia Scale in minority ethnic groups with different educational levels, in Guangxi. Zhonghua Liu Xing Bing Xue Za Zhi 32:1101-1104